The team at Wellstar Childrens Hospital of Georgia has a deep commitment to advancing pediatric care, expanding access, and investing in innovation
Efficacy and safety of co-administered once-weekly cagrilintide 24 mg with once-weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
The same is true of other GLP-1 medications
These are game-changing medications, says Shauna Levy, M.D., an obesity medicine physician at the Tulane University Medical Center in New Orleans and the medical director of Tulanes Bariatric and Weight Loss Center
These medications help regulate appetite and blood sugar, leading to significant weight loss when combined with lifestyle changes
Edens GLP-1 treatment program connects individuals to licensed healthcare providers who can guide your treatment and tailor a plan to support your goals.Please note that you must complete a health assessment and eligibility is not guaranteed
